Background
==========

Gastroesophageal reflux disease (GERD) represents an important medical problem in Western countries: about 20% of the population in Western countries complain of experiencing typical symptoms of this disease (heartburn and acid regurgitation). Furthermore, the incidence is probably underestimated, because many patients have extraesophageal symptoms such as asthma, cough, hoarseness and chest pain \[[@B1],[@B2]\].

GERD is associated with a variety of lesions, including esophageal erosion, ulceration, stricture and Barrett's esophagus. Reflux-related symptoms and lesions do not necessarily coexist, however, given that about 30% to 70% of patients who complain of typical symptoms have no signs of esophagitis based on endoscopy \[[@B1]\]. Therefore, nonerosive reflux disease (NERD) and erosive esophagitis (EE) represent the most common clinical features of GERD. The increasing use of 24-hour pH-metry allowed us to select patients with or without an increase in the acidification time of the esophagus.

Researchers who have evaluated differences between NERD and EE patients have found that patients with NERD have the following morphologic and functional patterns: lower esophageal sphincter (LES) pressure, minimal esophageal body motility abnormalities, lower esophageal acid exposure profile, low prevalence of hiatal hernia (HH) and minimal nighttime esophageal exposure. Moreover, NERD patients present with a lower incidence of acid reflux events than do patients with reflux esophagitis and Barrett's esophagus.

It has been suggested that NERD is a disease in itself, different from EE and Barrett's esophagus. Actually, it can be hard to diagnose NERD patients, either in either clinical practice or clinical research. NERD patients may present with symptoms as severe as those with EE, and the impairment in quality of life may be similar to that of GERD patients with or without endoscopically diagnosed esophagitis.

In the literature, investigators in different trials have compared patients with NERD with those with GERD, but without taking into account the degree of esophagitis. We that this represents a significant bias and could affect the data obtained from pH-metric and manometric tests.

Our aim in the present study was to compare the characteristics of reflux episodes in patients with NERD and EE, considering only those with hyperemia, edema, friability, pallor or erosions of the esophageal mucosa (grade I or II esophagitis according to the Savary-Miller classification).

Methods
=======

Between 2005 and January 2007, 215 patients with GERD symptoms were evaluated at the Department of Surgery, Tor Vergata University Hospital, Rome, and were included in this prospective, nonrandomized study. The study was approved by the Institutional Committee of the Tor Vergata University of Rome.

All patients underwent a complete evaluation, including esophagogastroduodenoscopy (EGDS), esophageal manometry with a six-channel computerized perfusion tube, and 24-hour esophageal pH monitoring using antimony monocrystalline electrodes with or without a separate skin reference electrode. In the presence of respiratory symptoms, antimony with two electrodes at 10 cm was adopted.

The 215 patients had neither undergone previous abdominal surgery nor used any kind of drugs influencing esophageal motility at the time of the clinical evaluation. Proton pump inhibitor (PPI) or H2 inhibitor therapy was interrupted at least 1 week before pH monitoring and esophageal manometry.

All patients with endoscopic findings of GERD were analyzed, but only patients with Savary-Miller grade I or II esophagitis were included. The following were the criteria for inclusion in the study:

1\. Patients with nonerosive esophagitis symptoms: mucosal changes such as erythema, edema, friability or pallor

2\. Patients with EE: erosions in the esophageal mucosa in addition to the changes mentioned in item 1

3\. Absence of endoscopic evidence of GERD, but with positive pH-metry

Pathologic reflux was assessed on the basis of the pH-monitoring pattern, even in the absence of features of esophagitis upon EGDS.

In addition to demographics, the presence of heartburn, dysphagia, noncardiac chest pain (NCCP) and respiratory symptoms possibly linked to reflux were recorded. In every patient who complained of asthmalike symptoms, retrosternal chest pain and pharyngeal constriction, pneumatological or otolaryngological evaluations were performed. HH was assumed to be present if the stomach protruded more than 2 cm through the esophageal hiatus.

Manometric studies were performed to evaluate the LES for amplitude, length and capacity of relaxation upon swallowing. The features and morphology of the swallowing complexes were analyzed together with the propagation of peristaltic waves in the body of the esophagus.

Intraesophageal pH readings were recorded using a Digitrapper pH 400 (Medtronic Functional Diagnostic A/S, Skovlunde, Denmark). An antimony pH catheter (Medtronic Inc, Minneapolis, MN, USA) was inserted transnasally with the patient under local anesthesia and placed 5 cm distal to the gastric cardia, and pH readings were recorded for 24 hours.

The analysis of the pH monitoring included the following parameters:

1\. Total number of reflux episodes

2\. Total number of pathological episodes of reflux (pH \< 4 for more than 5 minutes)

3\. Percentage of reflux time compared with total monitoring time (total reflux time)

4\. Percentage of reflux time compared with the time while the patient was in the upright position (reflux time in erect position)5. Percentage of reflux time compared with the time while the patient was lying down (reflux time in supine position)

5\. Johnson and DeMeester composite scoring system score (based on the above-mentioned parameters) \[[@B2]\]

The following are the normal values of the above-mentioned parameters:

1\. Total reflux time up to 3.2%

2\. Reflux time in erect position up to 8.2%

3\. Reflux time in supine position up to 3%

4\. Johnson and DeMeester score up to 14.7 (\>6 or 7 up to 10) \[[@B2]\]

Quality of life was assessed using the SF-36 health survey questionnaire for all patients.

Statistical analysis
--------------------

All statistical elaborations were obtained by using statistical software for Windows XP (Statgraphics, version 6). Results are expressed as values and standard deviation (means ± SD).

Nonparametric tests were used to analyze the results, taking into account the nature of the variables. The following tests were applied: Student's *t*-test for numerical data and a *χ*^2^ test with Yates's correction for qualitative data. In all tests, 0.05 or 5% was established as the level for rejecting the hypothesis.

Results
=======

Between 2005 and January 2007, 258 consecutive patients with GERD symptoms were evaluated at the Department of Surgery, Tor Vergata University Hospital, Rome. Of the 258 patients, 43 (16.7%) with Savary-Miller grade III or IV esophagitis were excluded from our study. Therefore, 215 patients were evaluated and included in this prospective, nonrandomized trial.

The baseline characteristics of the two groups are shown in Table [1](#T1){ref-type="table"}. Sixty-seven patients (31.2%) reported reflux associated with Savary-Miller grade I or II esophagitis (RE patients), and 148 patients (68.8%) showed no evidence of esophagitis (RE-free patients).

###### 

**Demographic characteristics of the 215 patients according to the presence or absence of reflux esophagitis**^**a**^

  **Demographic variables**   **RE patients,*n*(%)**   **RE-free patients,*n*(%)**   **Total patients,*n*(%)**
  --------------------------- ------------------------ ----------------------------- ---------------------------
  Number of patients          67 (31.2)                148 (68.8)                    215 (100)
  Men                         23 (34.3)                60 (40.5)                     83 (38.6)
  Women                       44 (65.7)                88 (59.5)                     132 (61.4)
  Age range, years (median)   24 to 74 (48.87)         17 to 73 (50.10)              17 to 74 (49.72)
  Total                       67 (100.0)               148 (100.0)                   215 (100.0)

^a^RE, reflux esophagitis.

There were no statistically significant differences between the two groups regarding presence of HH (*χ*^2^ = 0.259; *P* \> 0.05), LES pressure values (*χ*^2^ = 67.50; *P* \> 0.05) or total reflux time (*χ*^2^ = 55.50; *P* \> 0.05). Heartburn occurred in 38.8% of RE patients and 61.5% of the RE-free group, and the difference was statistically significant (Fisher's exact test; *P* \< 0.001). A significant association between heartburn and NCCP was recorded in 38.8% of RE patients and 9.4% of the RE-free group (*χ*^2^ = 24.811; *P* = 0.0001).

Retrosternal pain was more evident in RE-free than in RE patients (23.0% vs 17.9%, *χ*^2^ = 0.260; *P* \> 0.05), but the difference was not significant. Dysphagia was detected only in the RE group (4.5%, *χ*^2^ = 3.860; *P* = 0.049), and extraesophageal symptoms were noted only in the RE-free group (6.1%, *χ*^2^ = 2.871; *P* \> 0.05) (Table [2](#T2){ref-type="table"}).

###### 

**Clinical characteristics of the 215 patients according to the presence or absence of reflux esophagitis**^**a**^

  **Symptoms**               **RE patients,*n*(%)**   **RE-free patients,*n*(%)**   **Total patients,*n*(%)**   ***P*values**
  -------------------------- ------------------------ ----------------------------- --------------------------- ---------------
  Heartburn                  26 (38.8)                91 (61.5)                     117 (51.6)                  0.001
  Chest pain                 12 (17.9)                34 (23)                       46 (21.4)                   NS
  NCCP heartburn             26 (38.8)                14 (9.4)                      40 (18.6)                   0.0001
  Dysphagia                  3 (4.5)                  0 (0)                         3 (1.4)                     NS
  Extraesophageal symptoms   0 (0)                    9 (6.1)                       9 (4.2)                     NS
  Total                      67                       148                           215                          

^a^*NCCP*, noncardiac chest pain; *NS*, not statistically significant.

The results of manometric studies of the esophagus were substantially similar in the two groups of patients. The only statistically relevant difference was the length of the abdominal esophagus (*χ*^2^ = 14.24; *P* = 0.05) (Table [3](#T3){ref-type="table"}).

###### 

**Manometric pattern of the 215 patients according to the presence or absence of reflux esophagitis**^**a**^

  **Measured parameters**                                       **RE patients (mean values)**   **RE-free patients (mean values)**   ***P*values**
  ------------------------------------------------------------- ------------------------------- ------------------------------------ ---------------
  LES pressure (normal value = 14.3 to 34.5 mmHg)               15.3 mmHg                       16.8 mmHg                            NS
  Length of abdominal LES                                       1.1 cm                          1.6 cm                               0.05
  Amplitude pressure waves (normal value = 64 to 154)           74.7 mmHg                       73.8 mmHg                            NS
  Duration pressure waves (normal value = 2.9 to 5.1 seconds)   3.2 seconds                     3.1 seconds                          NS
  Motor alteration of esophageal body                           71.9%                           67.9%                                NS

^a^RE, reflux esophagitis; LES, lower esophageal sphincter; NS, not statistically significant.

Prolonged esophageal pH monitoring, carried out in all patients, showed no significant differences between the two groups regarding total reflux time or reflux time in either the erect or supine position (*χ*^2^ = 65.59; *P* \> 0.05). There was no significant difference in Johnson and DeMeester scores between RE patients and RE-free patients (F-ratio = 0.86; *P* \> 0.05) (Table [4](#T4){ref-type="table"}).

###### 

**pH-metric pattern of the 215 patients according to the presence or absence of reflux esophagitis**^**a**^

  **Measured parameters**       **RE patients (mean values)**   **RE-free patients (mean values)**   ***P*values**
  ----------------------------- ------------------------------- ------------------------------------ ---------------
  Total reflux number           140.6                           140.1                                NS
  Reflux number \>5 minutes     3.8                             2.7                                  NS
  pH time \<4 minutes           166.4                           109.5                                NS
  Reflux in supine and erect    69.6%                           76.9%                                NS
  Johnson and DeMeester score   32.8                            45.5                                 NS

^a^RE, reflux esophagitis; NS, not statistically significant.

Discussion
==========

A significant number of patients with classical esophageal reflux symptoms do not show endoscopic evidence of esophagitis. This group was regarded as having an attenuated form of gastroesophageal reflux (GER).

Kasapidis *et al.*\[[@B3]\] defined pathologic GER patients as only those with suggestive symptoms confirmed by pH monitoring. In accord with Nasi *et al.*\[[@B4]\], we do not agree with that definition, which does not take into account the significant group of symptomatic patients with esophagitis and normal pH-metry. Moreover, the failure of pH-metry to identify pathologic reflux in patients with esophagitis suggests that factors other than acidity, such as pepsin and bile salts, are involved in the pathogenesis of GERD.

Patients without endoscopic or pH-metric evidence of GER have been defined as having functional heartburn \[[@B3]\]. This may be due to hypersensitivity to acidic or other nonacidic factors, which could fire up their heartburn. On the other hand, increased sensibility to acid of esophageal chemoreceptors was found in patients without RE, even if they had a sensitivity to these factors lower than that of patients with EE \[[@B4]\].

On the basis of symptoms, the differential diagnosis between GERD with RE and NERD is really challenging. In our experience, patients with NERD complained of extraesophageal symptoms and retrosternal pain more often than RE patients and had a lower incidence of dysphagia. Nonetheless, these differences were not statistically significant.

In our series, in contrast to results reported by other authors, the impact of heartburn was significantly higher in patients without esophagitis than in those with it (*P* \< 0.001). Moreover, the presence of heartburn with pain was more frequent in patients with esophagitis than in those without it (*P* \< 0.0001).

In agreement with several other researchers, we found that the incidence of symptoms in GERD patients with versus without esophagitis is similar \[[@B5],[@B6]\]. Therefore, we cannot assume the presence of reflux disease with or without esophagitis based solely on symptoms.

EGDS in the present study detected HH in 144 patients overall (67%), comprising 47 patients (70%) in the esophagitis group and 97 patients (65.5%) in the nonesophagitis arm, without significant differences between the two groups. On the contrary, other authors have found a higher incidence of HH in patients with esophagitis \[[@B4],[@B7]\]. Actually, HH is considered a risk factor because it reduces esophageal clearance \[[@B4],[@B8]-[@B10]\]. Mittal *et al.*, who based their findings on esophageal scintigraphy to assess esophageal clearing time, observed that clearing time was shorter in patients with HH \[[@B9]\]. DeMeester *et al.* found an association between the presence of HH and severe acidic exposure of the esophageal mucosa detected by pH-metry \[[@B11]\].

Although total reflux time is considered the key factor in diagnosing GERD patients, in agreement with other authors, we found no difference among patients with versus those without esophagitis regarding total reflux time and Johnson and DeMeester score.

Likewise, Nasi *et al.*\[[@B4]\] believed that decreased resistance of the esophageal mucosa and the presence of harmful agents in the reflux (pepsin and/or bile salts), which are poorly assessed by esophageal pH monitoring, may contribute to GERD. Similarly, Pujol *et al.* found that there was no statistically significant difference in the number of episodes of reflux, time of reflux and Johnson and DeMeester score in patients with versus those without esophagitis \[[@B12]\].

In a pH-metric data analysis, Quigley *et al.* reported more than 75% of RE patients and about 50% to 65% of non-RE patients presented with alterations of esophageal acidification time \[[@B13]\]. In our experience, the presence of multiple episodes of pathological GER was found in 53.9% of patients with RE and in 52.2% of patients without RE (*P* \> 0.05).

Clinically high-grade esophagitis is often encountered in association with motility dysfunction of the lower esophagus and normal LES pressure values. In our experience, similar to that described by Almeida *et al.*\[[@B14]\], statistical analysis of esophageal motility parameters showed no significant difference between the two groups, with the exception of the length of the intraabdominal esophagus, which was longer in the group without RE (1.6 cm vs 1.1 cm; *P* \< 0.05).

Regarding the manometric pattern, in contrast to other authors who found motor impairments of the esophageal body in RE patients \[[@B4],[@B15]\], we found no difference between the two groups in terms of LES pressure and abdominal and total extension of the sphincter. On the contrary, Wu *et al.* found a higher prevalence of esophageal dysmotility in non-RE patient \[[@B4],[@B16]\]. Actually, patient selection is a key factor. In our study, patients with Savary-Miller grade III or IV esophagitis were not considered, in contrast to studies by other investigators who did not differentiate patients according to esophagitis grade.

Fass *et al.*\[[@B17]\] and Schindlbeck \[[@B18]\] found that in the emergency room, patient biopsies of the esophageal mucosa during EGDS could be another useful diagnostic tool. These authors reported a higher rate of inflammatory cells (for example, neutrophilic and eosinophilic granulocytes) as well as greater epithelial hyperplasia or mucosal vessel dilatation in histological specimens of both RE patients without esophagitis and non-RE patients with altered pH tests than in controls or non-RE patients with normal pH-metry \[[@B17],[@B18]\].

We found no difference in quality of life between the two groups, although we did not use specific questionnaires to evaluate the quality of life in the first part of our clinical experience. Previously, patients with endoscopy-negative reflux disease were considered to have milder disease. This concept is incorrect, given that the impact on quality of life is similar in GERD patients with or without esophagitis and is related to symptoms in both cases \[[@B17]-[@B20]\].

In patients who present with alarm symptoms, such as dysphagia, weight loss, anorexia and anemia, EGDS should be regarded as the first-line diagnostic approach. In contrast, patients who present with typical symptoms of GERD but without alarm symptoms will most likely be treated empirically, without the patient's or the physician's knowing whether there is an esophageal mucosal injury \[[@B21]\]. Only 25% of the patients without esophagitis who initially achieved complete symptom resolution while taking PPIs will remain symptom-free after 6 months without any antireflux therapy \[[@B22]\]. These findings suggest that most patients without esophagitis will require long-term therapy, regardless of the treatment that initially induces symptom remission.

Therefore, we do not agree with empirical PPI therapy, especially in young patients. We suggest performing continuous 24-hour pH monitoring in all patients to exclude or confirm the presence of duodenogastroesophageal reflux. Actually, the absence of pathological reflux during pH-metric monitoring could be useful by excluding the presence of acid reflux but cannot be used to detect episodes of alkaline refluxes, which can be investigated only with spectrophotometry of biliar pigments.

Conclusions
===========

In conclusion, we believe that NERD does not represent a different form of GERD, but that it should be considered an aspect of this condition with unique diagnostic and therapeutic features. Therapy must be tailored to each patient according to clinical and instrumental findings, especially in those patients who show good compliance and acceptable improvement in symptoms with "on-demand" or intermittent drug administration. Finally, surgery should be considered among the therapeutic options for well-selected patients with persistent reflux-associated symptoms and no endoscopic evidence of esophagitis, but with pathological pH values.
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